J&J to pay $181 million, ending suits
Johnson & Johnson will pay $181 million to resolve claims by 36 states that it improperly marketed and advertised the antipsychotic drugs Risperdal and Invega.
Join the discussion below, or Read more at Journal Gazette.
#1 Aug 31, 2012
I hope they can do this on people affected of their vaginal meshes. See http://www.vaginalmeshlawsuit.com/vaginal-mes...
#2 Sep 7, 2012
I think this is good news to all people whose lives are changed since they were implanted with DePuys hip replacement devices. And one thing though, I hope that DePuy will find a better way on how to improve their products safety so that patients may no longer be harmed in the future. For more information, you may refer at http://www.depuypinnaclelawsuit.com/hip-repla...
Add your comments below
|DePuy ASR Hip Lawsuit Update: Federal ASR Hip L... (Jul '13)||Aug '16||Dirk||2|
|2015 Osun state college of health tecgnology fo... (Apr '15)||Apr '15||Mr paul||1|
|US clears Johnson & Johnson hepatitis C drug (Nov '13)||Nov '13||WARNING FDA APPROVED||1|
|DePuy ASR Hip Recall: Status Conference Held in... (Jan '13)||Jul '13||Steve Austin||4|
|J&J to stop selling metal-on-metal hip replacem... (May '13)||Jul '13||Susan||2|
|New Market Report: DePuy Medical Device Company... (Jun '12)||Jul '13||Ray Lin||6|
|Lawsuits filed over recalled hip joints (Jul '11)||Jul '13||Bryan||10|
Find what you want!
Search DePuy Orthopaedics Forum Now
Copyright © 2017 Topix LLC